Sanofi wins US approval for drug combination to treat multiple myeloma
Sanofi won approval for the use of a drug combination with its Sarclisa infusion to treat certain types of newly diagnosed ...
Nasal Flu Vaccine Is Approved for At-Home Use
The F.D.A. authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a ...
US FDA approves AstraZeneca's flu vaccine for self-administration
FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...
San Francisco Examiner21h
FDA Says Drug Makers Will Stop Producing Fentanyl 'Lollipops'
Controversial fentanyl lollipops and similar products will no longer be made by drug makers, the U.S. Food and Drug ...
US FTC sues drug 'gatekeepers' over high insulin prices
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...
Food Safety Experts Won't Buy These 5 Items At The Grocery Store
Khubchandani also avoids most deli counter items and Detwiler is “not a fan of purchasing chicken or ground beef at the meat ...
Sanofi wins US approval for multiple myeloma drug in newly diagnosed patients
The U.S. Food and Drug Administration said on Friday it has approved the use of a drug combination along with Sanofi's ...
STAT14h
FDA approves first drug for rare neuron disease, Niemann-Pick type C
Parents pushed for years for treatments for the neuron disease Niemann-Pick type C. After setbacks, one drug now has FDA ...
KFGO15h
US FDA approves Zevra’s treatment for rare genetic disease
The U.S. Food and Drug Administration has approved Zevra Therapeutics' drug for a rare and fatal genetic disorder, making it ...
WBIW15h
FDA approves first nasal spray influenza vaccine for self or caregiver administration
INDIANA- Today, the U.S. Food and Drug Administration approved FluMist for self– or caregiver-administration. FluMist is ...
Times-News31m
HEALTH CARE BUZZ: Alzheimer’s: Diagnosed, Treatment and Stages, Part 2
By 2060, 14 million people will be living with Alzheimer’s, the fifth-leading cause of death in people 65 and older.